Bioelectronics Corp (BIEL)

[Daytime_Lantern]

Is the "All Musculoskeletal Pain" Actipatch device also subject to this "Challenge" thing, as well? I'm sorry, I don't understand why this "challenge" thing was added into the mix here? Maybe I missed something during the translation of why this is good for BIEL. Can someone help me out here? Did the CEO, during his latest interview, expound on why this recent FDA requirement was implemented, and maybe how it's beneficial to BIEL? To reiterate, can someone clarify just how does the "All Musculoskeletal Pain" clearance play within these new developments?

GLTA!!!